Nanospectra Biosciences' Unattributed Round

Nanospectra Biosciences raised a round of funding on February 10, 2017.

Nanospectra Biosciences is commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors while minimizing damage to healthy adjacent tissue and preserving …

Articles about Nanospectra Biosciences' Unattributed Round: